tiagabine has been researched along with fluorodeoxyglucose f18 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartenstein, P; Buchholz, HG; Chechko, N; Dielentheis, TF; Fehr, C; GrĂ¼nder, G; Hohmann, N; Landvogt, C; Schreckenberger, M; Urban, R; Yakushev, I | 1 |
Chow, C; Dougherty, DD; Evans, KC; Fischman, AJ; Gold, AL; Hoge, EA; Kaufman, RE; Pollack, MH; Rauch, SL; Simon, NM; Worthington, JJ | 1 |
2 trial(s) available for tiagabine and fluorodeoxyglucose f18
Article | Year |
---|---|
Tiagabine does not attenuate alcohol-induced activation of the human reward system.
Topics: Adult; Behavior, Addictive; Central Nervous System Depressants; Drug Synergism; Ethanol; Fluorodeoxyglucose F18; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; gamma-Aminobutyric Acid; Humans; Limbic System; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reward; Single-Blind Method; Tiagabine | 2007 |
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
Topics: Adult; Anxiety Disorders; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Positron-Emission Tomography; Prefrontal Cortex; Tiagabine | 2009 |